TBD

An innovative and fast-growing digital healthtech company based in Southern Italy is transforming the pharmaceutical retail sector through intelligent software and integrated logistics. The company offers a proprietary, cloud-base ...

TBD
TBD

Health Care Businesses For Sale

Find a Full List of Business for Sale, Health Care Businesses for sale, Buy Sell Side, Mergers & Acquisitions, Established Businesses for Sale at MergersCorp M&A International

An innovative and fast-growing digital healthtech company based in Southern Italy is transforming the pharmaceutical retail sector through intelligent software and integrated logistics. The company offers a proprietary, cloud-based platform that leverages AI and cutting-edge technology to optimize pharmacy operations, ensure drug traceability, and enhance therapeutic continuity—especially for vulnerable patient populations.

The firm operates a hybrid business model combining owned physical pharmacies, a modern pharmaceutical e-commerce platform, and a state-of-the-art logistics hub. Its vision is to build a fully digitized, highly efficient healthcare goods and services supply chain.

Investor Benefits

  • Tax Incentives: Recognized as an “innovative startup,” enabling investors to claim up to 30% of invested capital as a tax credit.

  • Low-Risk Profile: Active operations with strong execution track record.

  • High Market Potential: Addressing growing demand for digitized, efficient pharmacy services in Italy’s evolving healthcare landscape.

Investment Opportunity

The company is seeking €800K to accelerate its strategic expansion, including:

  • Acquiring 3 additional pharmacies to strengthen regional footprint.

  • Expanding warehouse capacity and integrating statistical tools to prevent medicine shortages.

  • Patent development for software integrated with national healthcare systems.

  • Enhancing the digital customer experience via a revamped web presence and internal process optimization.

Financial Snapshot (€‘000)

  • 2022 Revenue: €2.5M

  • 2023 Revenue: €3.5M

  • 2024 Revenue: €4.5M

  • 2025E Revenue: €5.0M

  • Steady EBITDA growth with improving margins projected.

Investment Size: 800,000 EUR

MergersCorp M&A
International As Seen On

  • brand 1
  • brand 1
  • brand 1
  • brand 1
  • brand 1